This patent covers the use of a peptide called BUF-5 for the treatment of anemia. Based on the literature we could not find what exactly BUF-5 is. This could be a very interesting patent for treatment not only of various forms of anemia, but also other hematological diseases in which stimulation of the erythrocyte progenitor is beneficial.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.